Increased Expression of miR-۲۰۲-۳p in Patients with Relapsing-Remitting Multiple Sclerosis

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 112

This Paper With 11 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JOBJ-6-4_002

تاریخ نمایه سازی: 14 اسفند 1400

Abstract:

Background and objectives: One of the latest studies in the genetics field is the evaluation of role of micro-RNAs as a biomarker for diagnosis of multiple sclerosis (MS), which is a demyelinating disease of the central nervous system (CNS) and emerges in the form of numerous small and large plaques in white matter in the brain and spinal cord. This disease could be associated with several complications, including reduced vision, spasticity and imbalance, and impaired sphincter control. MiR-۲۰۲-۳p is an intronic miRNA located in the ADA (Adenosine Deaminase) gene, which is the main enzyme involved in the pathway for the conversion of adenosine into inosine. Moreover, ADA regulates the inflammatory response and protection of tissue from damage as a strong complementary mechanism. This study aimed to evaluate the expression level of miR-۲۰۲-۳p in individuals diagnosed with relapsing-remitting multiple sclerosis (RRMS) and healthy individuals in Isfahan, Iran.   Methods: This analytical-observatory study was performed on ۴۹ RRMS patients and ۵۲ healthy individuals with no history of autoimmune and inflammatory diseases. Total RNA was extracted from blood lymphocytes by Ficoll and Trizol. Afterwards, cDNA was formed using a special miRNA cDNA kit, followed by the application of Real-time RT PCR to measure the expression of miR-۲۰۲-۳p in healthy individuals and patients.   Results: According to the results, the miR-۲۰۲-۳p expression was higher in patients, compared to healthy individuals (P=۰.۰۰۶). In addition, the sensitivity and diagnostic value of this miRNA in receiver operating characteristic (ROC) curve analysis were equal to AUC=۰.۸۰ (area under the curve).   Conclusion: In line with other studies, our findings demonstrated that miR-۲۰۲۳p can be used as a biomarker in the diagnosis of MS. In addition, it seems that miR-۲۰۲-۳p acts as an immunosuppressant by inhibiting ADA gene, which regulates various processes related to inflammatory response and maintenance of tissue from damage.

Authors

مجید امینی

Department of Genetics, Faculty of Basic Sciences, Shahrekord Islamic Azad University, Shahrekord, Iran.

پریسا محمدی نژاد

Department of Genetics, Faculty of Basic Sciences, Shahrekord Islamic Azad University, Shahrekord, Iran.

محمد مهدی مغنی باشی

Department of Genetics, Faculty of Basic Sciences, Kazerun Islamic Azad University, kazerun, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Rowland LP. Molecular genetics, pseudogenetics, and clinical neurology: The Robert ...
  • Olek M. Multiple sclerosis: etiology, diagnosis, and new treatment strategies: ...
  • Buc M. Role of regulatory T cells in pathogenesis and ...
  • Dutta R, Trapp BD. Pathogenesis of axonal and neuronal damage ...
  • Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. ...
  • Alcalde-Cabero E, Almazán-Isla J, GarcíaMerino A, de Sá J, de ...
  • Izadi S, Nikseresht A, Sharifian M, Sahraian MA, Jahromi AH, ...
  • Ramagopalan SV, Dyment DA, Valdar W, Herrera BM, Criscuoli M, ...
  • Van Horssen J, Witte ME, Schreibelt G, De Vries HE. ...
  • Farhana L, Dawson MI, Murshed F, Das JK, Rishi AK, ...
  • Huang Z, Huang S, Wang Q, Liang L, Ni S, ...
  • Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, ...
  • Gehring S, Rottmann S, Menkel AR, Mertsching J, Krippner-Heidenreich A, ...
  • Hurlin P, Foley K, Ayer D, Eisenman R, Hanahan D, ...
  • Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad ...
  • Lüscher B. MAD۱ and its life as a MYC antagonist: ...
  • Jiang Z, Guo J, Xiao B, Miao Y, Huang R, ...
  • Zhao Y, Li C, Wang M, Su L, Qu Y, ...
  • Yu J, Qiu X, Shen X, Shi W, Wu X, ...
  • Ratech H, Thorbecke GJ, Meredith G, Hirschhorn R. Comparison and ...
  • Ungerer J, Oosthuizen H, Bissbort S, Vermaak W. Serum adenosine ...
  • Maier SA, Galellis JR, McDermid HE. Phylogenetic analysis reveals a ...
  • Zavialov AV, Engström Å. Human ADA۲ belongs to a new ...
  • Tritsch GL, Niswander PW. Adenosine deaminase activity and superoxide formation ...
  • Sitkovsky MV, Ohta A. The 'danger'sensors that STOP the immune ...
  • Haskó G, Cronstein BN. Adenosine: an endogenous regulator of innate ...
  • Fredholm B. Adenosine, an endogenous distress signal, modulates tissue damage ...
  • Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, ...
  • Daddona PE. Human adenosine deaminase. Properties and turnover in cultured ...
  • Aldrich MB, Blackburn MR, Kellems RE. The importance of adenosine ...
  • Franco R, Pacheco R, Gatell JM, Gallart T, Lluis C. ...
  • Hasko G, Szabó C, Németh ZH, Kvetan V, Pastores S, ...
  • Németh ZH, Lutz CS, Csóka B, Deitch EA, Leibovich SJ, ...
  • Csóka B, Németh ZH, Virág L, Gergely P, Leibovich SJ, ...
  • Blackburn MR, Kellems RE. Adenosine deaminase deficiency: metabolic basis of ...
  • Nathan C. Points of control in inflammation. Nature. ۲۰۰۲;۴۲۰(۶۹۱۷):۸۴۶ ...
  • Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, ...
  • Cohen JE, Lee PR, Chen S, Li W, Fields RD. ...
  • Dugas JC, Notterpek L. MicroRNAs in oligodendrocyte and Schwann cell ...
  • Barca-Mayo O, Lu QR. Fine-tuning oligodendrocyte development by microRNAs. Frontiers ...
  • He X, Yu Y, Awatramani R, Lu QR. Unwrapping myelination ...
  • Zhao X, He X, Han X, Yu Y, Ye F, ...
  • Svaren J. MicroRNA and transcriptional crosstalk in myelinating glia. Neurochemistry ...
  • Lasley RD, Mentzer RM. Myocardial protection: the adenosine story. Drug ...
  • https://doi.org/۱۰.۱۰۰۲/(SICI)۱۰۹۸-۲۲۹۹(۱۹۹۶۱۱/۱۲)۳۹:۳/۴<۳۱۴::AID-DDR۱۱>۳.۰.CO;۲-۱Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, ...
  • https://doi.org/۱۰.۱۰۰۲/۱۰۹۸-۱۱۲۸(۲۰۰۱۰۳)۲۱:۲<۱۰۵::AID-MED۱۰۰۲>۳.۰.CO;۲-UHonma Y. A novel therapeutic strategy against monocytic leukemia with ...
  • Muddashetty R, Bassell GJ. A boost in microRNAs shapes up ...
  • Li J-S, Yao Z-X. MicroRNAs: novel regulators of oligodendrocyte differentiation ...
  • Fischer D, Van der Weyden MB, Snyderman R, Kelley WN. ...
  • Yagawa K, Okamura J. Role of adenosine deaminase in activation ...
  • Tritsch GL, Niswander PW. Purine catabolism as a source of ...
  • Sun Z, Zhang T, Hong H, Liu Q, Zhang H. ...
  • نمایش کامل مراجع